General Information of Drug-Metabolizing Enzyme (DME) (ID: DEOWDK1)

DME Name Oxygen-insensitive NADPH nitroreductase B (nfsB)
Synonyms Oxygen-insensitive NAD(P)H nitroreductase B; Dihydropteridine reductase; FMN-dependent nitroreductase; STM0578; pnrB
Gene Name nfsB
UniProt ID
NFSB_SALTY
INTEDE ID
DME1617
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Gene ID
1252098
EC Number EC: 1.5.1.34
Oxidoreductase
CH-NH donor oxidoreductase
NAD/NADP acceptor oxidoreductase
EC: 1.5.1.34
Lineage Species: Salmonella enterica
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Salmonella
Species: Salmonella enterica

Subspecies: Salmonella enterica subsp. enterica serovar Typhimurium TA100
Tissue Distribution Primarily distributed in human gut.
Sequence
MDIVSVALQRYSTKAFDPSKKLTAEEADKIKTLLQYSPSSTNSQPWHFIVASTEEGKARV
AKSAAGNYTFNERKMLDASHVVVFCAKTAMDDAWLERVVDQEDADGRFATPEAKAANDKG
RRFFADMHRVSLKDDHQWMAKQVYLNVGNFLLGVAAMGLDAVPIEGFDAEVLDAEFGLKE
KGYTSLVVVPVGHHSVEDFNAGLPKSRLPLETTLTEV
Function
This enzyme can reduce a variety of nitroaromatic compounds using NADH (and to lesser extent NADPH) as source of reducing equivalents; two electrons are transferred. And it also can reduce nitrofurazone.
KEGG Pathway
Microbial metabolism in diverse environments (stm01120 )
Nitrotoluene degradation (stm00633 )

Molecular Interaction Atlas (MIA) of This DME

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DME
1 Clinical Trial Drug(s) Metabolized by This DME
Drug Name Drug ID Indication ICD 11 Highest Status REF
AI3-23606 DMHMT49 N. A. N. A. Phase 1 [1]
3 Investigative Drug(s) Metabolized by This DME
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-chloro-5-nitro-N-phenylbenzamide DMUGQIV Discovery agent N.A. Investigative [2]
CL-205086 DMB6XUY N. A. N. A. Investigative [1]
Nitroimidazole DMMY2S5 Trypanosomiasis 1D51-1F53 Investigative [1]

References

1 Delamanid is not metabolized by Salmonella or human nitroreductases: a possible mechanism for the lack of mutagenicity. Regul Toxicol Pharmacol. 2017 Mar;84:1-8.
2 Effects of bacterial and presystemic nitroreductase metabolism of 2-chloro-5-nitro-N-phenylbenzamide on its mutagenicity and bioavailability. Chem Biol Interact. 2012 Apr 15;197(1):16-22.